Borbulevych, Oleg Y <br/><br/>
TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Sep 2011 
 - 2453-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.1101268  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cross Reactions<br/>Crystallography, X-Ray<br/>Genetic Therapy--methods<br/>HLA-A2 Antigen--chemistry<br/>Humans<br/>Immunotherapy--methods<br/>MART-1 Antigen--chemistry<br/>Neoplasms--immunology<br/>Protein Binding<br/>Protein Structure, Quaternary<br/>Protein Structure, Secondary<br/>Receptors, Antigen, T-Cell--chemistry<br/>T-Lymphocytes--chemistry